Kiora Pharmaceuticals (KPRX) Announces Chairman Retirement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. SPY
3. CHRW
4. MRVL
5. APLD
6. AMD
7. HUBS
8. RXO
9. OPCH
10. NVDA

Go back to Kiora Pharmaceuticals (KPRX) Announces Chairman Retirement

Kiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years

September 21, 2023 7:02 AM EDT

Encinitas, California--(Newsfile Corp. - September 21, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced that its board of directors has appointed Praveen Tyle, PhD, who currently serves as a director, as its new Chairman. Dr. Tyle succeeds current Chairman Paul Chaney who is retiring after serving 17 years on the board.

"We look forward to Dr. Tyle's leadership as Chairman, where he'll continue to bring valuable industry experience in guiding our development of new treatments for eye disease," said Brian M. Strem, PhD, President and CEO of Kiora. "We want to thank Paul... More